SNX18P5

Across TCGA pan-cancer cohorts, SNX18P5 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated SNX18P5 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher SNX18P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX18P5 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LIHC show a favorable association.

DLBC, COAD, and STAD are the cancer types where SNX18P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	84	view →
COAD	DFS	Tertile	IV	0.192	0.511	.003	78	view →
STAD	DFS	Tertile	All	0.173	0.412	.004	45	view →
THYM	OS	Tertile	All	0.554	0.936	.004	24	view →
BLCA	OS	Tertile	III,IV	0.824	0.347	.024	21	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
LUAD	OS	Tertile	IV	0.114	0.560	.038	18	view →
ESCA	DFS	Tertile	III,IV	0.258	0.474	.027	18	view →
LIHC	OS	Tertile	II,III,IV	0.852	0.583	.029	15	view →
KIRC	DFS	Quartile	All	0.858	0.570	.008	11	view →
SKCM	DFS	Tertile	III,IV	0.431	0.633	.016	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

SNX18P5–DLBC (OS)

Open the DLBC breakdown →